DOW JONES21,413.44+469.93 2.24%
S&P 5002,526.90+56.40 2.28%
NASDAQ7,487.31+126.73 1.72%

Craig-Hallum Reinstates Buy on NeoGenomics, Announces $38 Price Target

Craig-Hallum analyst Alex Nowark reinstates NeoGenomics (NASDAQ:NEO) with a Buy and announces $38 price target.

Benzinga · 03/02/2020 15:45

Craig-Hallum analyst Alex Nowark reinstates NeoGenomics (NASDAQ:NEO) with a Buy and announces $38 price target.